Aurora Kinases: New Targets for Cancer Therapy

The Aurora kinase family is a collection of highly related serine/threonine kinases that functions as a key regulator of mitosis. In mammalian cells, Aurora has evolved into three related kinases known as Aurora-A, Aurora-B, and Aurora-C. These kinases are overexpressed in a number of human cancers, and transfection studies have established Aurora-A as a bone fide oncogene. Because Aurora overexpression is associated with malignancy, these kinases have been targeted for cancer therapy. This article reviews the multiple functions of Aurora kinase in the regulation of mitosis and the mitotic checkpoint, the role of abnormal Aurora kinase activity in the development of cancer, the putative mechanisms of Aurora kinase inhibition and its antitumor effects, the development of the first generation of Aurora kinase inhibitors, and prospects for the future of Aurora kinase inhibition in the treatment of cancer.

[1]  G. Schwartz,et al.  A novel Aurora B kinase inhibitor with potent anticancer activity either as a single agent or in combination with chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Hirofumi Tanaka,et al.  Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway , 2000, Oncogene.

[3]  William Pao,et al.  Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Saya,et al.  RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. , 2005, Cancer research.

[5]  D. Berdnik,et al.  Drosophila Aurora-A Is Required for Centrosome Maturation and Actin-Dependent Asymmetric Protein Localization during Mitosis , 2002, Current Biology.

[6]  J. Schellens,et al.  Phase I and pharmacological study of the novel aurora kinase inhibitor AZD1152. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  David Bebbington,et al.  VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.

[8]  H. Saya,et al.  CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function. , 2003, Developmental cell.

[9]  J. Labbé,et al.  The D‐Box‐activating domain (DAD) is a new proteolysis signal that stimulates the silent D‐Box sequence of Aurora‐A , 2002, EMBO reports.

[10]  Mutsuko Ouchi,et al.  BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition* , 2004, Journal of Biological Chemistry.

[11]  A. Venkitaraman,et al.  AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. , 2003, Cancer cell.

[12]  E. Nigg,et al.  Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. , 2003, Molecular biology of the cell.

[13]  P. Stukenberg,et al.  Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis , 2002, Current Biology.

[14]  J. Peters,et al.  The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint , 2003, The Journal of cell biology.

[15]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[16]  C. Allis,et al.  Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases , 2002, Molecular and Cellular Biology.

[17]  D. Glover,et al.  Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles , 1995, Cell.

[18]  K. Connolly,et al.  Preclinical antitumor activity with MLN8054, a small molecule Aurora A kinase inhibitor , 2006 .

[19]  Patrick A. Eyers,et al.  A Novel Mechanism for Activation of the Protein Kinase Aurora A , 2003, Current Biology.

[20]  Roman Körner,et al.  Human TPX2 is required for targeting Aurora-A kinase to the spindle , 2002, The Journal of cell biology.

[21]  J. Schumacher,et al.  The Aurora-related kinase AIR-2 recruits ZEN-4/CeMKLP1 to the mitotic spindle at metaphase and is required for cytokinesis , 2000, Current Biology.

[22]  H. Saya,et al.  Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells , 2003, Cell.

[23]  B. Monsarrat,et al.  Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2–M transition , 2004, Journal of Cell Science.

[24]  G. Fang,et al.  Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex. , 2002, Molecular biology of the cell.

[25]  D. Ballinari,et al.  PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity , 2006, Clinical Cancer Research.

[26]  Yu-Li Wang,et al.  The Kinase Activity of Aurora B Is Required for Kinetochore-Microtubule Interactions during Mitosis , 2002, Current Biology.

[27]  P. Meraldi,et al.  Aurora‐A overexpression reveals tetraploidization as a major route to centrosome amplification in p53−/− cells , 2002, The EMBO journal.

[28]  B. Weaver,et al.  Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. , 2005, Cancer cell.

[29]  D. Bergstrom,et al.  A phase I clinical and pharmacokinetic (PK) trial of the aurora kinase (AK) inhibitor MK-0457 in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Eiji Kohmura,et al.  Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells* , 2003, Journal of Biological Chemistry.

[31]  A. Musacchio,et al.  The spindle checkpoint: structural insights into dynamic signalling , 2002, Nature Reviews Molecular Cell Biology.

[32]  K. Nasmyth,et al.  Evidence that the Ipl1-Sli15 (Aurora Kinase-INCENP) Complex Promotes Chromosome Bi-orientation by Altering Kinetochore-Spindle Pole Connections , 2002, Cell.

[33]  H. Katayama,et al.  Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. , 1998, Cancer research.

[34]  J. Shabanowitz,et al.  Aurora B Phosphorylates Centromeric MCAK and Regulates Its Localization and Microtubule Depolymerization Activity , 2004, Current Biology.

[35]  C. Prigent,et al.  A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly , 2003, Nature Cell Biology.

[36]  K. Nagata,et al.  Aurora-B Regulates the Cleavage Furrow-specific Vimentin Phosphorylation in the Cytokinetic Process* , 2003, The Journal of Biological Chemistry.

[37]  Andrea Musacchio,et al.  Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. , 2005, Molecular cell.

[38]  Samantha G. Zeitlin,et al.  CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis , 2001, The Journal of cell biology.

[39]  S. Nicosia,et al.  Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215* , 2004, Journal of Biological Chemistry.

[40]  S. Stewart,et al.  Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1. , 2005, Cancer research.

[41]  D. Glover,et al.  Drosophila Aurora B Kinase Is Required for Histone H3 Phosphorylation and Condensin Recruitment during Chromosome Condensation and to Organize the Central Spindle during Cytokinesis , 2001, The Journal of cell biology.

[42]  F. Ishikawa,et al.  MBD3 and HDAC1, Two Components of the NuRD Complex, Are Localized at Aurora-A-positive Centrosomes in M Phase* , 2002, The Journal of Biological Chemistry.

[43]  H. Katayama,et al.  Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. , 2002, Cancer research.

[44]  M. Loda,et al.  The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.

[45]  Stephen S. Taylor,et al.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.

[46]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[47]  Mutsuko Ouchi,et al.  1 BRCA 1 Phosphorylation by Aurora-A in the Regulation of G 2 to M Transition , 2004 .

[48]  H. Saya,et al.  Aurora-A — A guardian of poles , 2005, Nature Reviews Cancer.

[49]  Domenico Coppola,et al.  Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.